Code No. |
D198-3 |
Anti-CD93 (Human) mAb
|
Price |
¥46,200
|
Size |
100 µL (1 mg/mL) |
Availability (in Japan) |
10 or more
(In Japan at 00:05, Dec 14, 2024 in JST)
|
Clonality |
Monoclonal |
Clone |
mNI-11 |
Isotype
(Immunized Animal) |
Mouse IgG1 |
Applications |
IP 2 µg/400 µg of cell extract from 5x106 cells FCM 5 µg/mL (final concentration) IH 10 µg/mL (Can be used in cryosections.) Co-IP* reported. (PMID: 29763414)
|
Immunogen
(Antigen) |
LPS-stimulated U937 |
Reactivity [Gene ID] |
Human[22918] |
Storage buffer |
1 mg/mL in PBS/50% glycerol, pH 7.2 |
Storage temp. |
-20°C |
Conjugate |
Unlabeled |
Manufacturer |
MBL |
Alternative names |
C1qRp |
Background |
CD93, also known as C1qRp, is a 100-125 kDa type I membrane protein that is a receptor for the complement protein C1q. CD93 has also been shown to act as a receptor for mannose-binding lectin and surfactant protein A. CD93 is expressed on the surface of monocytes, granulocytes, and endothelial cells, and expression is increased by TNF-α or GM-CSF. CD93 is involved in ligand-mediated enhancement of phagocytosis and intercellular adhesion. |
Related products |
D198-5 Anti-CD93 (Human) mAb-PE
|
Product category |
Research area:Cell surface antigens |
Data |
|
Citations |
Western Blotting - Lugano R et al. CD93 promotes integrin-β1 activation and fibronectin fibrillogenesis during tumor angiogenesis. J Clin Invest. (2018) In press.(PMID:29763414)
Co-IP - Lugano R et al. CD93 promotes integrin-β1 activation and fibronectin fibrillogenesis during tumor angiogenesis. J Clin Invest. (2018) In press.(PMID:29763414)
Flow Cytometry - McGreal EP et al. Human C1qRp is identical with CD93 and the mNI-11 antigen but does not bind C1q. J Immunol. 15, 5222-32 (2002)(PMID:11994479)
Immunocytochemistry - Lugano R et al. CD93 promotes integrin-β1 activation and fibronectin fibrillogenesis during tumor angiogenesis. J Clin Invest. (2018) In press.(PMID:29763414)
- Barbera S et al. The small GTPase Rab5c is a key regulator of trafficking of the CD93/Multimerin-2/β1 integrin complex in endothelial cell adhesion and migration. Cell Commun Signal. 17, 55 (2019)(PMID:31138217)
|
References |
- Ikewaki N, Inoko H. Development and characterization of a novel monoclonal antibody (mNI-11) that induces cell adhesion of the LPS-stimulated human monocyte-like cell line U937. J Leukoc Biol. 59, 697-708 (1996)(PMID: 8656055)
- Ikewaki N et al. A unique monoclonal antibody mNI-11 rapidly enhances spread formation in human umbilical vein endothelial cells. J Clin immunol. 20, 317-24 (2000)(PMID: 10939719)
- McGreal EP et al. Human C1qRp is identical with CD93 and the mNI-11 antigen but does not bind C1q. J Immunol. 168, 5222-32 (2002)(PMID: 11994479)
- Ikewaki N et al. Regulation of CD93 cell surface expression by protein kinase C isoenzymes. Microbiol Immunol. 50, 93-103 (2006)(PMID: 16490927)
- Ikewaki N et al. Decrease in CD93 (C1qRp) expression in a human monocyte-like cell line (U937) treated with various apoptosis-inducing chemical substances. Microbiol Immunol. 51, 1189-200 (2007)(PMID: 18094537)
- Ikewaki N et al. Flow cytometric identification of CD93 expression on naive T lymphocytes (CD4(+)CD45RA (+) cells) in human neonatal umbilical cord blood. J Clin Immunol.30, 723-33 (2010)(PMID: 20512406)
- Ikewaki N et al. Unique properties of cluster of differentiation 93 in the umbilical cord blood of neonates. Microbiol Immunol. 57, 822-32 (2013)(PMID: 24033555)
- Ikewaki N et al. Serum levels of soluble CD93 in patients with chronic renal failure. J. of Kyushu Univ. of Health and Welfare 17, 81-8 (2016)
- Nativel B et al. CD93 is a cell surface lectin receptor involved in the control of the inflammatory response stimulated by exogenous DNA. Immunology. 158, 85-93 (2019)(PMID: 31335975)
- Małgorzata K et al. Soluble Complement Component 1q Receptor 1 (sCD93) Is Associated with Graft Function in Kidney Transplant Recipients. Biomolecules.11(11) 1623 (2021)(PMID: 34827620)
|